Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
Authors
Keywords
Multiple myeloma, Allogeneic transplantation, OS, PFS, RR, Death rate, TRM, GVHD
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-23
DOI
10.1186/s12935-018-0553-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work
- (2017) Qaiser Bashir et al. Current Hematologic Malignancy Reports
- Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series
- (2016) Attaphol Pawarode et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
- (2016) Eric Smith et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
- (2016) V. Hoyos et al. BLOOD
- Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival
- (2016) Binod Dhakal et al. Clinical Lymphoma Myeloma & Leukemia
- Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution
- (2016) Laurens E. Franssen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Tandem autologous versus autologous/allogeneic transplantation for multiple myeloma: propensity score analysis
- (2016) Koji Kawamura et al. LEUKEMIA & LYMPHOMA
- Is it possible to cure myeloma without allogeneic transplantation?
- (2016) Eirini Katodritou et al. TRANSFUSION AND APHERESIS SCIENCE
- Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
- (2015) Yvan Beaussant et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution
- (2015) L Rosiñol et al. BONE MARROW TRANSPLANTATION
- Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation
- (2015) I Ahmad et al. BONE MARROW TRANSPLANTATION
- Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
- (2015) F Sahebi et al. BONE MARROW TRANSPLANTATION
- Trends and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma at Mayo Clinic
- (2015) Muhammad A. Mir et al. Clinical Lymphoma Myeloma & Leukemia
- Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
- (2015) Taku Kikuchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- How we manage autologous stem cell transplantation for patients with multiple myeloma
- (2014) M. A. Gertz et al. BLOOD
- The future of autologous stem cell transplantation in myeloma
- (2014) F. van Rhee et al. BLOOD
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma
- (2013) Jean El-Cheikh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors in Multiple Myeloma: Study from the Italian Bone Marrow Donor Registry
- (2013) Roberto Passera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study
- (2013) G. Gahrton et al. BLOOD
- Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation
- (2013) H W Auner et al. BONE MARROW TRANSPLANTATION
- Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma
- (2013) T Nishihori et al. BONE MARROW TRANSPLANTATION
- Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation
- (2013) C O Freytes et al. BONE MARROW TRANSPLANTATION
- Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients
- (2013) Teresa Caballero-Velázquez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bortezomib Plus Dexamethasone Followed by Escalating Donor Lymphocyte Infusions for Patients with Multiple Myeloma Relapsing or Progressing after Allogeneic Stem Cell Transplantation
- (2012) Vittorio Montefusco et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Impact of High-Risk Cytogenetics and Achievement of Molecular Remission on Long-Term Freedom from Disease after Autologous–Allogeneic Tandem Transplantation in Patients with Multiple Myeloma
- (2012) Nicolaus Kröger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Darwinian evolution and tiding clones in multiple myeloma
- (2012) N. J. Bahlis BLOOD
- Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study
- (2012) H. M. Lokhorst et al. BLOOD
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Comparison of early quality of life outcomes in autologous and allogeneic transplant patients
- (2012) C M Garcia et al. BONE MARROW TRANSPLANTATION
- Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients
- (2012) N Kröger et al. BONE MARROW TRANSPLANTATION
- Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT
- (2012) S Gerull et al. BONE MARROW TRANSPLANTATION
- Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database
- (2012) N S Majhail et al. BONE MARROW TRANSPLANTATION
- Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study
- (2012) Firoozeh Sahebi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma
- (2012) Jean El-Cheikh et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project
- (2012) H Avet-Loiseau et al. LEUKEMIA
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
- (2011) Qaiser Bashir et al. AMERICAN JOURNAL OF HEMATOLOGY
- Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed after Autograft: A Multicenter Retrospective Study Based on Donor Availability
- (2011) Francesca Patriarca et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma
- (2011) L. Giaccone et al. BLOOD
- Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis
- (2011) S. Kumar et al. BLOOD
- Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
- (2011) O Ringdén et al. BONE MARROW TRANSPLANTATION
- Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia – A Single-Institution Experience
- (2011) Karthik Ramasamy et al. Clinical Lymphoma Myeloma & Leukemia
- Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)
- (2011) C. Fabre et al. HAEMATOLOGICA
- Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
- (2011) D. Roos-Weil et al. HAEMATOLOGICA
- Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up
- (2011) Bo Björkstrand et al. JOURNAL OF CLINICAL ONCOLOGY
- Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial
- (2011) Amrita Krishnan et al. LANCET ONCOLOGY
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
- (2011) K D Boyd et al. LEUKEMIA
- Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998–2006: factors associated with improved survival outcome
- (2011) Ian Nivison-Smith et al. LEUKEMIA & LYMPHOMA
- Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
- (2010) Keren Osman et al. AMERICAN JOURNAL OF HEMATOLOGY
- Long-Term Follow-Up of an Intensified Myeloablative Conditioning Regimen with In Vivo T Cell Depletion Followed by Allografting in Patients with Advanced Multiple Myeloma
- (2010) Nicolaus Kröger et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma
- (2010) Yvonne A. Efebera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-Intensity Conditioning Followed by Related Allografts in Hematologic Malignancies: Long-Term Outcomes Most Successful in Indolent and Aggressive Non-Hodgkin Lymphomas
- (2010) Erica D. Warlick et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Refining "total therapy" for myeloma
- (2010) J. Blade et al. BLOOD
- Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
- (2010) L Karlin et al. BONE MARROW TRANSPLANTATION
- Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience
- (2010) M C Minnema et al. BONE MARROW TRANSPLANTATION
- EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT
- (2010) S Jamshed et al. BONE MARROW TRANSPLANTATION
- Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma
- (2010) Avichai Shimoni et al. CANCER
- Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)
- (2010) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of Second Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning with Fludarabine and Melphalan after a Failed Autologous Hematopoietic Stem Cell Transplantation
- (2010) J.Y. Hong et al. TRANSPLANTATION PROCEEDINGS
- Partial T Cell-Depleted Allogeneic Stem Cell Transplantation following Reduced-Intensity Conditioning Creates a Platform for Immunotherapy with Donor Lymphocyte Infusion and Recipient Dendritic Cell Vaccination in Multiple Myeloma
- (2009) Henriëtte Levenga et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13
- (2009) D. Reece et al. BLOOD
- Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
- (2009) P. Kapoor et al. BLOOD
- Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
- (2009) Nicolaus Kröger et al. BRITISH JOURNAL OF HAEMATOLOGY
- Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention
- (2009) Joseph Pidala et al. BRITISH JOURNAL OF HAEMATOLOGY
- Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma
- (2009) Luciano J. Costa et al. LEUKEMIA & LYMPHOMA
- Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo
- (2008) B. Bruno et al. BLOOD
- A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma
- (2008) L. Rosinol et al. BLOOD
- Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting
- (2008) M. Rotta et al. BLOOD
- Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
- (2008) H de Lavallade et al. BONE MARROW TRANSPLANTATION
- Prevention of graft vs. host disease with alemtuzumab ‘in the bag’ decreases early toxicity of stem cell transplantation and in multiple myeloma is associated with improved long-term outcome
- (2008) N. Novitzky et al. CYTOTHERAPY
- Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
- (2008) G Schilling et al. LEUKEMIA
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument
- (2007) L. Wettergren et al. PSYCHO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started